169 related articles for article (PubMed ID: 37994411)
21. Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer-INCAGI004.
Araujo RO; Vieira FM; Victorino AP; Torres C; Martins I; Guaraldi S; Valadão M; Linhares E; Ferreira CG; Thuler LC
Support Care Cancer; 2022 Aug; 30(8):6557-6572. PubMed ID: 35486228
[TBL] [Abstract][Full Text] [Related]
22. Postoperative radiochemotherapy in rectal cancer comparison of two combination schemes: alternating versus concomitant.
Valencia J; Escó R; Polo S; Bascón N; Escudero P; Alonso V
Tumori; 2004; 90(2):216-24. PubMed ID: 15237585
[TBL] [Abstract][Full Text] [Related]
23. Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.
Lawrie TA; Green JT; Beresford M; Wedlake L; Burden S; Davidson SE; Lal S; Henson CC; Andreyev HJN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012529. PubMed ID: 29360138
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report.
Lee JH; Lee JH; Ahn JH; Bahng H; Kim TW; Kang YK; Lee KH; Kim JC; Yu CS; Kim JH; Ahn SD; Kim WK; Kim SH; Lee JS
J Clin Oncol; 2002 Apr; 20(7):1751-8. PubMed ID: 11919231
[TBL] [Abstract][Full Text] [Related]
25. Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial.
Miller RC; Sargent DJ; Martenson JA; Macdonald JS; Haller D; Mayer RJ; Gunderson LL; Rich TA; Cha SS; O'Connell MJ
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):409-13. PubMed ID: 12243815
[TBL] [Abstract][Full Text] [Related]
26. Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.
Shamseddine A; Zeidan YH; Kreidieh M; Khalifeh I; Turfa R; Kattan J; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Khoury C; El Husseini Z; Charafeddine M; Al Darazi M; Geara F
BMC Cancer; 2020 Sep; 20(1):831. PubMed ID: 32873251
[TBL] [Abstract][Full Text] [Related]
27. Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.
Lupattelli M; Maranzano E; Bellavita R; Natalini G; Corgna E; Rossetti R; Trippa F; Mascioni F; Sidoni A; Anselmo P; Buzzi F; Brugia M; Latini P
Tumori; 2005; 91(6):498-504. PubMed ID: 16457149
[TBL] [Abstract][Full Text] [Related]
28. A Phase II trial of neoadjuvant preoperative chemoradiotherapy with S-1 plus irinotecan and radiation in patients with locally advanced rectal cancer: clinical feasibility and response rate.
Sato T; Ozawa H; Hatate K; Onosato W; Naito M; Nakamura T; Ihara A; Koizumi W; Hayakawa K; Okayasu I; Yamashita K; Watanabe M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):677-83. PubMed ID: 21035953
[TBL] [Abstract][Full Text] [Related]
29. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
30. Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.
Yamazaki T; Gunderson AJ; Gilchrist M; Whiteford M; Kiely MX; Hayman A; O'Brien D; Ahmad R; Manchio JV; Fox N; McCarty K; Phillips M; Brosnan E; Vaccaro G; Li R; Simon M; Bernstein E; McCormick M; Yamasaki L; Wu Y; Drokin A; Carnahan T; To Y; Redmond WL; Lee B; Louie J; Hansen E; Solhjem MC; Cramer J; Urba WJ; Gough MJ; Crittenden MR; Young KH
Lancet Oncol; 2022 Sep; 23(9):1189-1200. PubMed ID: 35952709
[TBL] [Abstract][Full Text] [Related]
31. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
32. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
[TBL] [Abstract][Full Text] [Related]
33. Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial.
Liu S; Wang X; Zhuang Y; Bai S; Wu X; Ye Y; Luo H; Yu H; Wang Q; Chang H; Zeng Z; Cai P; Pan Z; Gao Y; Chen G; Xiao W
Cancer Med; 2023 Jun; 12(12):13352-13360. PubMed ID: 37156624
[TBL] [Abstract][Full Text] [Related]
34. A clinical study on the nutritional status of patients with locally advanced rectal cancer during chemo-radiotherapy.
Bai SX; Wang WL; Zhou HQ; Dong HM; Wang G; Chen WW; Li GD; Chen J; Lu D; Mo BR
Ann Ital Chir; 2023; 94():73-81. PubMed ID: 36810299
[TBL] [Abstract][Full Text] [Related]
35. Substantial reduction in severe diarrheal morbidity by daily zinc supplementation in young north Indian children.
Bhandari N; Bahl R; Taneja S; Strand T; Mølbak K; Ulvik RJ; Sommerfelt H; Bhan MK
Pediatrics; 2002 Jun; 109(6):e86. PubMed ID: 12042580
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of short-term efficacy of perioperative fecal microbiota transplantation combined with nutritional support in patients with radiation-induced enteritis complicated by intestinal obstruction].
Cui JQ; Tian HL; Wang XJ; Wang L; Liu YK; Ye C; Ding LF; Li N; Chen QY
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):955-962. PubMed ID: 37849266
[No Abstract] [Full Text] [Related]
37. Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms.
Guan X; Wei R; Yang R; Lu Z; Liu E; Zhao Z; Chen H; Yang M; Liu Z; Jiang Z; Wang X
JAMA Netw Open; 2021 Jan; 4(1):e2031661. PubMed ID: 33416884
[TBL] [Abstract][Full Text] [Related]
38. A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer.
Navarro M; Dotor E; Rivera F; Sánchez-Rovira P; Vega-Villegas ME; Cervantes A; García JL; Gallén M; Aranda E
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):201-5. PubMed ID: 16814947
[TBL] [Abstract][Full Text] [Related]
39. A prospective study of nutritional supplementation for preventing oral mucositis in cancer patients receiving chemotherapy.
Okada T; Nakajima Y; Nishikage T; Ryotokuji T; Miyawaki Y; Hoshino A; Tokairin Y; Kawada K; Nagai K; Kawano T
Asia Pac J Clin Nutr; 2017 Jan; 26(1):42-48. PubMed ID: 28049260
[TBL] [Abstract][Full Text] [Related]
40. Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E).
Chen Y; Wang Y; Zhang H; Wan J; Shen L; Wang Y; Zhou M; Wu R; Yang W; Zhou S; Cai S; Li X; Zhang Z; Xia F
BMJ Open; 2023 Oct; 13(10):e076048. PubMed ID: 37802608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
